Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy

Journal of Internal Medicine, 04/27/2012

The incorporation of oestrogen response elements (ERE) single–nucleotide polymorphisms into models with known predictors might improve outcome prediction in patients with prostate cancer receiving androgen–deprivation therapy.

Print Article Summary